Dr. Gail Roboz was interviewed Tuesday, November 20th about Myelodysplastic Syndrome. Watch the interview below.
Leukemia & Lymphoma Society Awards $1.8 Million to Weill Cornell for Translational Research in Blood CancersPosted: August 31, 2012
New Translational Research Grants Awarded to Accelerate Promising Blood Cancer Research Discoveries from the Laboratory to the Patients’ Bedside. Read the press release here.
For more information on the Leukemia and Lymphoma Society, click here.
For information on the Guzman Lab and the research of Monica Guzman, PhD, click here.
For information on the laboratory of Dr. Duane Hassane, click here.
Two Leukemia Program physicians, Dr. Gail Roboz and Dr. Karen Carlson were asked to speak at the 2011 American Society of Hematology (ASH) Annual Meeting in San Diego.
Leukemia Program Director, Dr. Gail Roboz, gave a presentation titled, “Novel Approaches to the Treatment of AML” during the “Acute Myeloid Leukemia in the Age of Genomics” session. Dr. Roboz also contributed to the 2011 Hematology Education Program Book.
Dr. Karen Carlson gave an oral presentation during the session, “Hematopoiesis and Stem Cells- Microenvironment, Cell Adhesion and Stromal Stem Cells: Regulators of the Stem Cell Niche,” and authored an abstract titled “Laminin is Necessary for Maintenance of the Vascular Hematopoietic Niche.”
ASH is the world’s largest professional society concerned with the causes and treatments of blood disorders. For information about ASH, click here.
Sandra Allen-Bard, BSN, MSN, AOCNP, ANCC has won the Leukemia and Lymphoma Society’s (LLS) National Chairman’s Citation for 2011. This is the second Chairman’s Citation for Ms. Allen-Bard, who was also recognized for her outstanding contributions by LLS in 2009.
The Chairman’s Citation recognizes the outstanding accomplishments of individuals who have demonstrated significant dedication and commitment to their chapter and are deserving of national recognition. The award is also given to medical institutions, organizations, social workers or caregivers who have given outstanding support, counsel or guidance to blood cancer patients and their families.
Nominations for the Chairman’s Citation may be made throughout the year at the community level and for presentation by chapters.